Feng Wang
Institute of Biophysics
Chinese Academy of Sciences
China
Biography
1993- 1998, B.S. , University of Science and Technology of China 1998- 2002, M.S., Northwestern University 2003- 2007, Ph.D., Texas A&M University 2007- 2012, Postdoctoral Fellow, The Scripps Research Institute 2012- present, Principal Investigator, California Institute for Biomedical Research 2017 - present: Professor, Institute of Biophysics, Chinese Academy of Sciences 1993- 1998, B.S. , University of Science and Technology of China 1998- 2002, M.S., Northwestern University 2003- 2007, Ph.D., Texas A&M University 2007- 2012, Postdoctoral Fellow, The Scripps Research Institute 2012- present, Principal Investigator, California Institute for Biomedical Research 2017 - present: Professor, Institute of Biophysics, Chinese Academy of Sciences
Research Interest
•Oncology •Metabolic and Cardiovascular Disease •Autoimmune and Inflammatory Disease •Tissue-specific Therapeutic Strategies •Enhancing the Pharmacology of Therapeutic Proteins and Peptides •Bispecific Antibodies and Engineered T cells
Publications
-
Renhe Liu, Xiaoxuan Lyu, Sarah M Batt, Mei-Hui Hsu, Michael B Harbut, Catherine Vilchèze, Bo Cheng, Kehinde Ajayi, Baiyuan Yang, Yun Yang, Hui Guo, Changyou Lin, Fei Gan, Chen Wang, Scott G. Franzblau, William R. Jacobs Jr., Gurdyal S. Besra, Eric F. Johnson, Mike Petrassi, Arnab K. Chatterjee, Klaus Fütterer, Feng Wang*, Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes, Angew Chem. Int. Ed. Engl., 2017, 56，13011-13015
